SCHEMBL14464280

SCHEMBL14464280

CCC(C)c1nc2ccccc2c(-c2ccc(F)c(C(C)C)c2)c1/C=C/C1CC(O)CC(=O)O1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HMGCR P04035 11/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13992370 0.87 HMGCR (0.61) HMGCR
SCHEMBL8571000 0.83 HMGCR (0.71) HMGCR
SCHEMBL8321853 0.83 HMGCR (0.71) HMGCR
SCHEMBL10661873 0.83 HMGCR (0.71) HMGCR
SCHEMBL9023237 0.77 HMGCR (0.85) HMGCR
SCHEMBL9022402 0.77 HMGCR (0.85) HMGCR
SCHEMBL13994086 0.77 HMGCR (0.61) HMGCR
SCHEMBL13992367 0.76 HMGCR (0.49) HMGCR
SCHEMBL10665630 0.76 HMGCR (0.66) HMGCR
SCHEMBL10662722 0.76 HMGCR (0.66) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1810971-A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia SCHERING CORPORATION (US) 2007-07-25 — — EP disclosed
Send feedback